| Front Page |
|
Mattson is New Chief of GRC Laboratory
Marcetich Heads NLM Indexing Section
NIDDK Council Gains Four Four new members have joined the advisory council of the National Institute of Diabetes and Digestive and Kidney Diseases. They are: Dr. Edward J. Benz, Jr., Sir William Osler professor and director, department of medicine, and professor of molecular biology and genetics, Johns Hopkins University School of Medicine. He is a member of the Institute of Medicine and an NIH-funded investigator studying the molecular genetics of inherited anemias. The Hon. Levan Gordon, who recently retired as judge of the Court of Common Pleas of Philadelphia. Currently a member of the board of directors of the National Kidney Foundation, he is past chair of the National Association of Blacks in Criminal Justice. Dr. Edward W. Holmes, dean, Duke University School of Medicine, Walter Kempner professor of medicine and vice-chancellor for academic affairs at Duke University Medical Center. He is currently an NIDDK Merit Award grantee studying the pathobiology of AMP deaminase deficiency. Dr. Sandra Puczynski, assistant professor of family medicine and director, division of research and evaluation, Medical College of Ohio. She is chair of the research advisory board and a member of the board of directors of the Juvenile Diabetes Foundation International.
Klein To Head AABB
Dr. Harvey Klein, chief of the Clinical Center's department of transfusion medicine, was recently voted president-elect of the American Association of Blood Banks. His 1-year term begins in November. He has been on the AABB's board of directors for the past 6 years and chaired the association's research-funding entity, the National Blood Foundation, when it was created a decade ago. Established in 1947, the AABB sets standards for blood collection and transfusion, provides education and certification for physicians and medical personnel, and assesses institutions involved in the collection and processing of blood products. Klein's primary responsibilities as president will be strategic planning and leadership on blood transfusion issues, both national and international. Up to Top |